arrow
M

Marcel Romanos

university of munich
H指数:53
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Therapeutic drug monitoring in children and adolescents treated with quetiapine for different psychiatric disorders: results of the TDM-VIGIL pharmacovigilance study

儿童和青少年使用喹硫平治疗不同精神障碍的药物浓度监测:TDM-VIGIL 药物警戒研究的结果

2026-08-170
OAAI
Prescribing trends and spontaneous reporting patterns of adverse drug reactions of ADHD medications in children and adolescents in germany: A retrospective analysis (2013–2022)

德国儿童和青少年注意缺陷多动障碍药物处方的趋势及不良药物反应的自发报告模式:一项回顾性分析(2013–2022)

2026-04-270
OA
Adult ADHD with comorbid major depression shows a distinguishable polygenic pattern and negative cognitive style

成人注意缺陷多动障碍伴发重度抑郁症表现出可区分的多基因模式和消极认知风格

2026-04-040
OAAI
Parental psychosocial factors associated with parental reporting of their child’s administrative ADHD diagnosis - results from the consortium project INTEGRATE-ADHD

与父母报告其子女行政性ADHD诊断相关的父母心理社会因素——来自整合ADHD研究联盟项目(INTEGRATE-ADHD)的结果

2025-11-060
OAAI
Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial

儿童和青少年使用抗抑郁药和抗精神病药的标签外用药:一项前瞻性多中心试验的结果

2025-10-150
OAAI
Extinction learning and return of fear in a large sample of children and adolescents with and without anxiety disorders

消退学习与恐惧重现:在患有和未患有焦虑障碍的大样本儿童和青少年中的研究

2025-08-300
OAAI
Utilization of Mental Health Care Services Among Children and Adolescents with ADHD in Germany: Treatment Satisfaction and Factors Influencing Access

德国儿童和青少年注意缺陷多动障碍(ADHD)患者心理健康服务利用率:治疗满意度及影响获取服务的因素

2025-08-120
OA
Therapeutic drug monitoring in children and adolescents with schizophrenia-spectrum, affective, behavioural, tic and other psychiatric disorders treated with aripiprazole: results of the TDM-VIGIL pharmacovigilance study
2024-11-020
OAAI
The impact of the COVID-19 pandemic on administrative eating disorder prevalence in the outpatient sector and on severity of anorexia nervosa
2024-07-201
OAAI
Clinical high risk state of major depressive episodes: Assessment of prodromal phase, its occurrence, duration and symptom patterns by the instrument the DEpression Early Prediction-INventory (DEEP-IN)
2024-04-012
OAAI